Diabetic Peripheral Neuropathy: Nerve Conduction Studies Before, During and After Carbamazepine Therapy
- 1 December 1976
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 6 (6) , 565-568
- https://doi.org/10.1111/j.1445-5994.1976.tb03996.x
Abstract
Summary: Diabetic peripheral neuropathy: Nerve conduction studies before, during and after carbamazepine therapy. A. K. Chakrabarti and S. K. Samantaray, Aust. N.Z. J. Med., 1976, 6, pp. 565–568.Fifty‐four patients with diabetic peripheral neuropathy were treated with carbamazepine for a period of one year. Clinical assessment and nerve conduction velocity studies (NCV) were done periodically. Forty‐nine patients had symptomatic relief of all sensory manifestations but NCV remained essentially unchanged. Untoward effects of the drug were frequent but transitory. It was concluded that carbamazepine is a dependable drug for the treatment of symptomatic diabetic sensory polyneuropathy.This publication has 5 references indexed in Scilit:
- Effect of Diphenylhydantoin on Glucose Tolerance in Patients with HypoglycemiaDiabetes, 1974
- Neurological Changes in Early DiabetesPublished by Elsevier ,1973
- Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol®): Double blind crossover trialDiabetologia, 1969
- Carbamazepine for Tabetic PainJAMA, 1968
- Central Action of G-32883 Upon Transmission of Trigeminal Pain ImpulsesPharmacology, 1965